DRD2 and cancer: Cmax exceeded the preclinical therapeutic threshold of 1 μg/mL based on DRD2/ClpP target engagement and anti-cancer activity.10–12,14 The mean volume of distribution was 187 L (SD, 138L), consistent with a large distributive volume.